Probiotic Interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the Opportunistic Fungal Pathogen Candida albicans
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Candida albicans is the most important Candida species causing vulvovaginal candidiasis (VVC). VVC has significant medical and economical impact on women’s health and wellbeing. While current antifungal treatment is reasonably effective, supportive and preventive measures such as application of probiotics are required to reduce the incidence of VVC. We investigated the potential of the probiotics Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 towards control of C. albicans.In vitro experiments demonstrated that lactic acid at low pH plays a major role in suppressing fungal growth. Viability staining following cocultures with lactobacilli revealed that C. albicans cells lost metabolic activity and eventually were killed. Transcriptome analyses showed increased expression of stress-related genes and lower expression of genes involved in fluconazole resistance, which might explain the increased eradication of Candida in a previous clinical study on conjoint probiotic therapy. Our results provide insights on the impact of probiotics on C. albicans survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“The CDR1 gene encoding an important drug efflux pump involved in fluconazole resistance [21, 24, 25] appears also on the list of genes with significantly lower expression (Table 2(c)).”
BackgroundCandida Infections of the Genitourinary Tract
Achkar, J. M., & Fries, B. C. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00076-09 · Cited by 736 · cited 1×
“Estimates on the occurrence of VVC point to at least one episode of VVC in 75% of all women [1–3].”
BackgroundWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Enjalbert, B., Smith, D. A., Cornell, M. J., Alam, I., Nicholls, S., Brown, A. J. P., & Quinn, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0501 · Cited by 381
Metabolic specialization associated with phenotypic switching in Candida albicans
Lan, C.-Y., Newport, G., Murillo, L. A., Jones, T., Scherer, S., Davis, R. W., & Agabian, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566499 · Cited by 275 · cited 1×
“albicans GeneChips were described previously [12].”
PHR1 , a pH-Regulated Gene of Candida albicans , is Required for Morphogenesis
Saporito-Irwin, S. M., Birse, C. E., Sypherd, P. S., & Fonzi, W. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.601 · Cited by 264 · cited 1×
“albicans [30, 31].”
The pH of the Host Niche Controls Gene Expression in and Virulence of Candida albicans
De Bernardis, F., Mühlschlegel, F. A., Cassone, A., & Fonzi, W. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.7.3317-3325.1998 · Cited by 258
The metabolic basis of Candida albicans morphogenesis and quorum sensing.
Han, T.-L., Cannon, R. D., & Villas-Bôas, S. G. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.04.002 · Cited by 173 · cited 1×
“albicans and inhibits the invasive hyphal form of these fungi [28, 29].”
Background
Cited by
The mycobiota: interactions between commensal fungi and the host immune system
Underhill, D. M., & Iliev, I. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3684 · Cited by 695
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Current perspectives on antifungal lactic acid bacteria as natural bio-preservatives
Crowley, S., Mahony, J., & van Sinderen, D. (2013) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2013.07.004 · Cited by 328
Isolation of vaginal lactobacilli and characterization of anti-candida activity
Parolin, C., Marangoni, A., Laghi, L., Foschi, C., Ñahui Palomino, R. A., Calonghi, N., Cevenini, R., & Vitali, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131220 · Cited by 228
Matsubara, V. H., Wang, Y., Bandara, H. M. H. N., Mayer, M. P. A., & Samaranayake, L. P. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7527-3 · Cited by 206
“albicans biofilms by downregulating the genes involved in biofilm development as well as those associated with DNA replication, translation, glycolysis, and gluconeogenesis (Chew et al. 2015a; Kohler et al. 2012).”
BackgroundInfluentialProbiotics as antifungals in mucosal candidiasis
Matsubara, V. H., Bandara, H. M. H. N., Mayer, M. P. A., & Samaranayake, L. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw038 · Cited by 151
Probiotics as an adjunct therapy for the treatment of halitosis, dental caries and periodontitis
Bustamante, M., Oomah, B. D., Mosi-Roa, Y., Rubilar, M., & Burgos-Díaz, C. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-019-9521-4 · Cited by 142
Changes in vaginal microbiota following antimicrobial and probiotic therapy
Macklaim, J. M., Clemente, J. C., Knight, R., Gloor, G. B., & Reid, G. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.27799 · Cited by 134
Self-citationProbiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro
Jørgensen, M. R., Kragelund, C., Jensen, P. Ø., Keller, M. K., & Twetman, S. (2017) · Journal of Oral Microbiology · doi:10.1080/20002297.2016.1274582 · Cited by 107
The Complex Link between the Female Genital Microbiota, Genital Infections, and Inflammation
Dabee, S., Passmore, J.-A. S., Heffron, R., & Jaspan, H. B. (2021) · Infection and Immunity · doi:10.1128/iai.00487-20 · Cited by 89
Graf, K., Last, A., Gratz, R., Allert, S., Linde, S., Westermann, M., Gröger, M., Mosig, A. S., Gresnigt, M. S., & Hube, B. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039719 · Cited by 83
“This can likely be attributed to the buffered KBM cell culture medium (required to keep the epithelial cells healthy in our model), which kept the pH neutral throughout the experiment and thus dampened any potential antimicrobial effect of lactic acid shown in other studies at acidic pH (Buffo et al., 1984; Hasslöf et…”
InfluentialMailänder-Sánchez, D., Braunsdorf, C., Grumaz, C., Müller, C., Lorenz, S., Stevens, P., Wagener, J., Hebecker, B., Hube, B., Bracher, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184438 · Cited by 59
Is Candida albicans a contributor to cancer? A critical review based on the current evidence
Wang, X., Zhang, W., Wu, W., Wu, S., Young, A., & Yan, Z. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127370 · Cited by 44
The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis
Baldewijns, S., Sillen, M., Palmans, I., Vandecruys, P., Van Dijck, P., & Demuyser, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.705779 · Cited by 44
Mollazadeh-Narestan, Z., Yavarikia, P., Homayouni-Rad, A., Samadi Kafil, H., Mohammad-Alizadeh-Charandabi, S., Gholizadeh, P., & Mirghafourvand, M. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09997-3 · Cited by 29
Leonova, M. V. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-13-148-154 · Cited by 4
Metadata
- Authors
- Köhler, G. A., Assefa, S., & Reid, G.
- Venue
- Infectious Diseases in Obstetrics and Gynecology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-14
- ISSN
- 1064-7449 (ISSN-L)
- 1098-0997
- OpenAlex
- W2050939128
- Cited by
- 152
- References
- 16
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.